4150 Federal Register / Vol. 78, No. 13 / Friday, January 18, 2013 / Notices 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Master of a vessel or person in 

charge of a conveyance.

42 CFR 70.4 Report by the master of a vessel or 

person in charge of conveyance of the incidence of 

a communicable disease occurring while in interstate travel (Paper Form if requested by CDC during public health emergency).

1,500 1 15/60 

State health authority ....................... 42 CFR 70.4 Copy of material submitted to state or 

local health authority under this provision (Paper 

Form if requested by CDC during public health 

emergency).

20 75 6/60 

Master of a vessel or person in 

charge of a conveyance.

42 CFR 70.4 Report by the master of a vessel or 

person in charge of conveyance of the incidence of 

a communicable disease occurring while in interstate travel (Radio or other telecommunication for 

routine reporting).

200 1 15/60 

State health authority ....................... 42 CFR 70.4 Copy of material submitted to state or 

local health authority under this provision (Radio or 

other telecommunication for routine reporting).

200 1 15/60 

Traveler ............................................ 42 CFR 70.5 Application for a permit to move from 

State to State while in the communicable period.

3,750 1 15/60 

Attending physician .......................... 42 CFR 70.5 Application for a permit to move from 

State to State while in the communicable period.

3,750 1 15/60 

Dated: January 10, 2013. 

Ron A. Otten, 

Director, Office of Scientific Integrity (OSI), 

Office of the Associate Director for Science 

(OADS), Office of the Director Centers for 

Disease Control and Prevention. 

[FR Doc. 2013–00987 Filed 1–17–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Office for State, Tribal, Local and 

Territorial Support (OSTLTS) Meeting; 

Correction 

SUMMARY: This document corrects a 

notice that was published in the Federal 

Register on January 7, 2013 (78 FR 949– 

950). The 10th Biannual Tribal 

Consultation session has been 

postponed to coincide with the summer 

2013 meetings; the dates will be 

announced once they are determined. 

The Tribal Advisory Committee Meeting 

will be extended and held February 5, 

6, and 7, 2013, from 8:00 a.m.–4:30 p.m. 

FOR FURTHER INFORMATION CONTACT: 

Kimberly Cantrell, Deputy Associate 

Director for Tribal Support, OSTLTS, 

via mail to 4770 Buford Highway NE., 

MS E–70, Atlanta, Georgia 30341 or 

email to klw6@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: January 11, 2013. 

John Kastenbauer, J.D., 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–00989 Filed 1–17–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[CDC–2013–0001; NIOSH–134–B] 

Update of NIOSH Nanotechnology 

Strategic Plan for Research and 

Guidance 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Request for Information: Update 

of NIOSH Nanotechnology Strategic 

Plan for Research and Guidance. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) seeks 

comment on the types of hazard 

identification and risk management 

research that should be considered for 

updating the NIOSH FY2013–FY2016 

nanotechnology strategic plan. This 

draft strategic plan (Protecting the 

Nanotechnology Workforce: NIOSH 

Nanotechnology Research and 

Guidance Strategic Plan 2013–2016) can 

be found in Docket CDC–2013–0001 at 

http://www.regulations.gov. 

DATES: Comments must be received 

March 19, 2013. 

ADDRESSES: You may submit comments, 

identified by CDC–2013–0001 and 

Docket Number NIOSH–134–B, by 

either of the two following methods: 

• Federal erulemaking portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: NIOSH Docket Office, Robert 

A. Taft Laboratories, MS–C34, 4676 

Columbia Parkway, Cincinnati, OH 

45226. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

(CDC–2013–0001; NIOSH–134–B). All 

relevant comments received will be 

posted without change to http:// 

www.regulations.gov, including any 

personal information provided. For 

access to prior background documents 

or previous comments received, go to 

http://www.cdc.gov/niosh/docket/ 

archive/docket134.html and http:// 

www.cdc.gov/niosh/docket/archive/ 

docket134A.html. 

FOR FURTHER INFORMATION CONTACT: 

Charles L. Geraci, NIOSH, Robert A. Taft 

Laboratories, MS–C14, 4676 Columbia 

Parkway, Cincinnati, Ohio 45226, 

telephone (513) 533–8339. 

SUPPLEMENTARY INFORMATION: 

Background 

Since 2004, the National Institute for 

Occupational Safety and Health 

mstockstill on DSK4VPTVN1PROD with 

Federal Register / Vol. 78, No. 13 / Friday, January 18, 2013 / Notices 4151 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) has 

pioneered research on the toxicological 

properties and characteristics of 

nanoparticles. This research has 

involved characterizing occupationally 

relevant nanoparticles for predicting 

whether these particles pose a risk of 

adverse health effects and for providing 

guidance on controlling workplace 

exposures. In September 2005, NIOSH 

developed a strategic plan to further 

guide the Institute in identifying and 

prioritizing nanotechnology research. In 

2009 this strategic plan [http:// 

www.cdc.gov/niosh/docs/2010-105] was 

updated based on knowledge gained 

from results of ongoing NIOSH research 

[see Progress Toward Safe 

Nanotechnology in the Workplace; A 

Report from the NIOSH Nanotechnology 

Research Center http://www.cdc.gov/ 

niosh/docs/2007-123/] and from the 

public and stakeholder input. NIOSH 

would like to build on the 

accomplishments of ongoing research 

[http://www.cdc.gov/niosh/docs/2013- 

101/ and http://www.cdc.gov/niosh/ 

docs/2010-104/] to develop strategic 

research goals and objectives for 

nanotechnology occupational safety and 

health research through 2016. NIOSH 

has identified 10 critical research areas 

for nanotechnology research and 

communication. These 10 critical 

research areas are (1) Toxicity and 

internal dose, (2) measurement 

methods, (3) exposure assessment, (4) 

epidemiology and surveillance, (5) risk 

assessment, (6) engineering controls and 

personal protective equipment (PPE), (7) 

fire and explosion safety, (8) 

recommendations and guidance, (9) 

global collaborations, and (10) 

applications. 

NIOSH is considering focusing the 

overarching strategic research goals for 

these critical areas on 5 key objectives: 

(1) Increase understanding of new 

hazards and related health risks to 

nanomaterial workers; (2) Expand 

understanding of the initial hazard 

findings on engineered nanomaterials; 

(3) Support the creation of guidance 

materials to inform nanomaterial 

workers, employers, health 

professionals, regulatory agencies, and 

decision-makers about hazards, risks, 

and risk management approaches; (4) 

Support epidemiologic studies for 

nanomaterial workers, including 

medical and exposure studies; and 5) 

Assess and promote national adherence 

with risk management guidance. 

NIOSH requests public input to 

address the following: 

(1) What is the basis or rationale for 

priorities that NIOSH should give for 

studies of toxicity evaluation and/or 

workplace exposure characterization for 

engineered nanoparticles? 

(2) What rationale can be provided for 

recommending needs and types of 

technical and educational guidance 

materials? 

Dated: January 14, 2013. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–00994 Filed 1–17–13; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3278–N] 

Medicare Program; Request for 

Information on Hospital and Vendor 

Readiness for Electronic Health 

Records Hospital Inpatient Quality 

Data Reporting; Extension of Comment 

Period 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Request for information; 

extension of the comment period. 

SUMMARY: This notice extends the 

comment period for a request for 

information (RFI) which was published 

in the January 3, 2013 Federal Register 

(78 FR 308). The RFI requests that 

hospitals, electronic health record (EHR) 

vendors, and other interested parties 

respond to questions regarding their 

readiness to conduct electronic 

reporting of certain patient-level data 

under the Hospital Inpatient Quality 

Reporting (IQR) Program using the 

Quality Reporting Document 

Architecture (QRDA) Category I. The 

comment period for the RFI, which 

would have ended on January 22, 2013, 

is extended to February 1, 2013. 

DATES: The comment period for the 

request for information published in the 

January 3, 2013 Federal Register (78 FR 

308) is extended to February 1, 2013. 

ADDRESSES: In commenting, please refer 

to file code CMS–3278–NC. Because of 

staff and resource limitations, we cannot 

accept comments by facsimile (FAX) 

transmission. 

You may submit comments in one of 

four ways (please choose only one of the 

ways listed): 

1. Electronically. You may submit 

electronic comments on this regulation 

to http://www.regulations.gov. Follow 

the instructions under the ‘‘More Search 

Options’’ tab. 

2. By regular mail. You may mail 

written comments to the following 

address ONLY: Centers for Medicare & 

Medicaid Services, Department of 

Health and Human Services, Attention: 

CMS–3278–NC, P.O. Box 8013, 

Baltimore, MD 21244–8013. 

Please allow sufficient time for mailed 

comments to be received before the 

close of the comment period. 

3. By express or overnight mail. You 

may send written comments to the 

following address ONLY: Centers for 

Medicare & Medicaid Services, 

Department of Health and Human 

Services, Attention: CMS–3278–NC, 

Mail Stop C4–26–05, 7500 Security 

Boulevard, Baltimore, MD 21244–1850. 

4. By hand or courier. If you prefer, 

you may deliver (by hand or courier) 

your written comments before the close 

of the comment period to either of the 

following addresses: 

a. For delivery in Washington, DC— 

Centers for Medicare & Medicaid 

Services, Department of Health and 

Human Services, Room 445–G, Hubert 

H. Humphrey Building, 200 

Independence Avenue, SW., 

Washington, DC 20201. 

(Because access to the interior of the 

Hubert H. Humphrey Building is not 

readily available to persons without 

Federal government identification, 

commenters are encouraged to leave 

their comments in the CMS drop slots 

located in the main lobby of the 

building. A stamp-in clock is available 

for persons wishing to retain a proof of 

filing by stamping in and retaining an 

extra copy of the comments being filed.) 

b. For delivery in Baltimore, MD— 

Centers for Medicare & Medicaid 

Services, Department of Health and 

Human Services, 7500 Security 

Boulevard, Baltimore, MD 21244–1850. 

If you intend to deliver your 

comments to the Baltimore address, 

please call telephone number (410) 786– 

9994 in advance to schedule your 

arrival with one of our staff members. 

Comments mailed to the addresses 

indicated as appropriate for hand or 

courier delivery may be delayed and 

received after the comment period. 

Submission of comments on 

paperwork requirements. You may 

submit comments on this document’s 

paperwork requirements by following 

the instructions at the end of the 

‘‘Collection of Information 

Requirements’’ section in this 

document. 

For information on viewing public 

comments, see the beginning of the 

SUPPLEMENTARY INFORMATION section. 

FOR FURTHER INFORMATION CONTACT: 

Maria Harr, (410) 789–6710. 

mstockstill on DSK4VPTVN1PROD with